Why Size Matters

Why Size Matters in Cold Plasma Therapy: How SteriPlas Redefines Safety and Efficacy in Wound Treatment

In the fast-evolving world of medical technology, size often seems to shrink in tandem with innovation. Smaller, more portable devices flood the market, promising convenience and versatility, but sometimes critical aspects of functionality can be compromised. Adtec Healthcare’s SteriPlas, a groundbreaking microwave cold plasma device for wound treatment, boldly defies this trend, emphasizing that when it comes to effective and safe medical treatment, bigger truly is better.

 

SteriPlas: Leading with Power, Safety, and Precision

At a time when competitors are striving for compactness, the SteriPlas stands out with its larger design, which is purposefully engineered to deliver an unmatched level of therapeutic cold plasma. Unlike smaller Cold Plasma devices, the SteriPlas was built to prioritize treatment potency and safety without compromising on effectiveness. But why exactly does size matter for the SteriPlas? The answer lies in its ability to generate a rich, dense cold microwave plasma field that smaller devices simply can’t match.

 

Delivering Dense Cold Plasma for Optimal Therapeutic Effect

Cold plasma, a unique, non-thermal form of energized gas, has become a significant breakthrough in wound care due to its ability to kill bacteria.  However, the efficacy of cold plasma therapy hinges on both the density and consistency of the plasma field, which is directly impacted by the device’s design.

The SteriPlas, with its larger structure, is engineered to generate and sustain a denser, richer microwave argon plasma field. This dense field ensures that cold plasma thoroughly reaches the treatment area, making it more effective at eradicating harmful pathogens and promoting healing. Where smaller devices might struggle to deliver a consistent plasma , the SteriPlas provides a comprehensive, evenly distributed cold plasma field, amplifying its therapeutic benefits.

 

Prioritizing Safety with No Side Effects

The SteriPlas was also designed with patient safety as a top priority. Despite its larger size and higher plasma density, it remains exceptionally safe for patients,  no reported side effects—a critical advantage in any therapeutic device. Smaller devices may sometimes trade off treatment efficacy to meet compact design requirements, but the SteriPlas’s size is integral to its uncompromising safety standards.

Cold plasma therapy’s expanding use in wound treatment has led to a surge in demand for devices that are not only effective but also safe for prolonged and repeated use. SteriPlas’s larger design enables it to incorporate advanced safety protocols that allow it to maintain a rich microwave plasma field without risking tissue damage or other side effects. This design ensures that the SteriPlas can safely treat sensitive areas and deliver results consistently over time.

 

Setting a New Standard in Cold Plasma Therapy

The SteriPlas represents a thoughtful balance of innovation, efficacy, and patient-centered design, challenging the notion that smaller is always better. While compact devices may offer some portability, the SteriPlas delivers a level of cold plasma density and therapeutic power that smaller devices cannot replicate. This enhanced efficacy, combined with its rigorous safety measures, positions SteriPlas as an ideal choice for clinics and healthcare providers seeking the best outcomes for their patients.

 

In wound care, where every treatment counts, the SteriPlas’s larger design is not just a feature—it’s a necessity. It’s a testament to Adtec Healthcare’s commitment to ensuring that patients receive the highest standard of care without compromise.

 

Conclusion

As cold plasma therapy continues to grow in its applications, healthcare professionals face an important decision in choosing devices that prioritize both treatment potency and patient safety. With its robust, thoughtfully engineered design, the SteriPlas offers an unparalleled therapeutic solution that addresses both needs, setting a new benchmark in cold plasma wound therapy. Adtec Healthcare invites clinicians to explore the SteriPlas difference, where bigger means better, safer, and more effective healing.

 


What makes our SteriPlas safe and effective?

What makes our SteriPlas Premium Cold Plasma safe and effective?

 

Adtec has been the global leader of Cold Plasma medicine, having developed Cold Plasma products for over 20 years and being the first company worldwide to conduct clinical trials on wounds. In total, Adtec boasts over 80+ clinical trials and studies with no side effects reported.

 

Whilst there are many forms of Cold Plasmas on the market, our SteriPlas Cold Plasma is dense and slowly propelled towards the treatment site enabling bacterial destruction in deep and hard to reach infection areas. The argon Cold Plasma is microwave, 2.45GHz generated using crucial components within the body of the medical device. This is why it is larger in size but at the advantage of delivering reliable and consistent results and easily tackles complicated biofilm issues within chronic infections unlike the other variations of Cold Plasma on the market. This is also why our clinical evidence is often cited by other Cold Plasma manufacturers as our promising results far outweigh the results achieved by Cold Plasma devices with different plasma designs.

 

To learn more about our strengths and benefits, contact us at info@adtecplasma.com


Leading the way in Cold Plasma Medicine

The antibiofilm properties of the SteriPlas has been widely documented across our 80+ clinical trials and studies. It is being widely used to treat a multitude of infection conditions such as Diabetic Foot Ulcers, Sternal Wounds and LVAD infections in the UK, EU and SE Asia. Helping to significantly reduce morbidity, mortality, amputation and bed occupancy rates, the SteriPlas has been transforming modern medicine by simplifying and accelerating the way these chronic and non-healing wounds are treated. We have also documented the significant cost saving benefits of using the SteriPlas Premium Cold Plasma all with the added benefit of no side effects due to its safe, microwave 2.45GHz argon plasma generation.

 

To learn more about the benefits we can bring you, contact us at info@adtecplasma.com


Sitting at the forefront of the Cold Plasma market

There's a reason why we're the leaders of Cold Plasma.

Adtec Healthcare Ltd has been at the forefront of Cold Plasma by having the most experience on the market. We have invested years of gathering strong clinical evidence all the way from being the first company worldwide to introduce Cold Plasma on wounds in clinical trials many years ago to having our medical device widely adopted in hospitals across the UK and Europe.

The SteriPlas is the only Cold Plasma medical device with anti-biofilm efficacy by having dense, rich, microwave-driven Cold Plasma. No side effects have been reported with the use of our medical device.

To learn about the #mythbusting on Cold Plasma visit our webpage: https://adtechealthcare.com/cold-plasma-wound-treatment/

#MEDICA2023 #ABHI #ABHI2023 #Medicaldistributor #Investors


Advanced Wound Care Summit 2023

We hope you got to see our presentation at the Advanced Wound Care Summit yesterday. We thoroughly enjoyed explaining the strong benefits of our SteriPlas Cold Plasma for biofilm destruction. If you would like to learn more about our medical device and clinical evidence, send us an email info@adtecplasma.com


Adtec Healthcare Ltd to showcase at the LSX Conference in London

We’re on a mission to revolutionize the global wound care market! Adtec Healthcare is participating in the LSX Conference in London.

 

Our managing director, Mary McGovern shall present our cold plasma technology at the MedTech Showcase on Thursday 4th May at 11:30 am.

 

We have developed SteriPlas, a medical device for the treatment of chronic wounds. The most effective cold plasma technology for wound care treatment, proven by clinical studies.  The device uses proven antibacterial cold atmospheric argon plasma to treat chronic wounds, dermatology, and post-operative wound infections.  Enables faster healing, reduces hospital stays, eliminates biofilms and the use of antibiotics. CE Marked and available for sale in UK and EU. Efficacy proven in 70+ peer-reviewed clinical studies.  Early adoption by leading wound care specialists. Strong IP portfolio, comprising of granted and recently submitted patents covering various aspects of their device.

 

We are currently speaking to investors to accelerate sales in Europe and for the launch in the US. At LSX, we are meeting investors and partners interested in medical devices and wound care.

Please contact us at info@adtecplasma.com to arrange a meeting.

 

https://www.lsxleaders.com/lsx-world-congress/agenda/medtech


SteriPlas heals wounds quickly

Did you catch the leading Serbian media newspaper, Večernje Novosti, last week? Our SteriPlas was featured in the article, “Cold plasma heals wounds quickly” composed by Dr Zorić.

Dr Zoric has been using our cold plasma medical device to treat hard-to-heal and stalled wounds infected with biofilm. These problematic wounds have responded very well with our SteriPlas treatment and patients have been healed that were otherwise stalled by conventional therapies.

 

If you are within Serbia and interested to learn more about our medical device, contact our medical distributor Borf Health Care on info@borf.biz for more information.

 


Successful meetings held at the Taiwan Society for Plastic Surgery

We are happy to report an eventful exhibition over the weekend at the Taiwan Society for Plastic Surgery led by our distributor in Taiwan. This is the first time the Adtec SteriPlas has set foot in Taiwan so naturally there was a lot of interest in our medical device. We look forward supporting our distributor for the exciting year ahead.

For more information about our medical device, contact us at info@adtecplasma.com


Safe UV and Reactive Species levels only with the Adtec SteriPlas

As a leading medical device company, the crucial balance of safety and clinical efficacy are a top priority. We are always conducting tests to demonstrate the approved safety and reliability of the Adtec SteriPlas but to also learn new ways to improve the use of cold plasma in medicine.

 

Our clinical studies already validate the safety of the Adtec SteriPlas, including its low-level UV and reactive species produced from the cold plasma. These two components are imperative for the physical destruction of bacteria, however, too much of a good thing can also be relatively damaging like that observed with cold plasma jet/pens and battery powered cold plasma devices.

 

Measured across multiple distances, the UV light produced is well below the ICNIRP limit of 30 J/m2 and the reactive species produced are well below the occupational limits set by NIOSH and UK HSE. The Adtec SteriPlas continues to be one of the only cold plasma medical devices that puts patient and user safety first with no reported side effects and promising clinical efficacy from every treatment conducted.

For more information about the Adtec SteriPlas, send us an email at info@adtecplasma.com


Adtec Healthcare prepares for exhibition in July

We are very excited to be exhibiting at the Malvern Diabetic Foot Conference between 7-9th July. This will be our first physical exhibition participation in over a year! Be sure to visit us and see our cold plasma medical device live in action, perfect for the treatment of chronic DFUs infected with biofilm.